Xiaofeng Zhang
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
Papers in
- Hepatology 11
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Liver physiology and pathology 4
- Oncology 22
- Cancer Cells and Metastasis 9
- Pancreatic and Hepatic Oncology Research 4
- Cancer-related Molecular Pathways 3
Xiaofeng Zhang
42 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 97
- Hepatology 355
- Cancer Research 345
- Oncology 453
- Immunology 127
- Molecular Biology 362
Countries citing papers authored by Xiaofeng Zhang
This map shows the geographic impact of Xiaofeng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Zhang more than expected).
Fields of papers citing papers by Xiaofeng Zhang
This network shows the impact of papers produced by Xiaofeng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Zhang. The network helps show where Xiaofeng Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 8 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 18 | |
| 8 | 2021 | 20 | |
| 9 | 2021 | 17 | |
| 10 | 2021 | 22 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 18 | |
| 13 | 2018 | 80 | |
| 14 | 2018 | 32 | |
| 15 | 2017 | 10 | |
| 16 | 2016 | 58 | |
| 17 | 2015 | 3 | |
| 18 | 2014 | 101 | |
| 19 | 2011 | 20 | |
| 20 | Clinical Observation of "Zhixiao Powder" in Treating Bronchial Asthma by Cutaneous Penetration | 2007 | 1 |
About Xiaofeng Zhang
Xiaofeng Zhang is a scholar working on Hepatology, Oncology, Cancer Research, Cell Biology and Immunology, having authored 44 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Liver physiology and pathology (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer-related Molecular Pathways (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Hepatology (355 citations), Cancer Research (345 citations), Oncology (453 citations), Immunology (127 citations) and Molecular Biology (362 citations). Xiaofeng Zhang has collaborated with scholars based in China, Hong Kong and France. Frequent co-authors include Jun Li, Feng Shen, Wan Yee Lau, Bin Sun, Zhengfeng Yin, Lehua Shi, Haihua Qian, Lei Chen, Haihua Qian and Yanming Zhou. Their work appears in journals such as Cancer Biology & Therapy, Cancer Letters, Oncotarget, PLoS ONE and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.